Omega is a leading international Life Sciences-focused investment firm operating from London and Boston offices.

Omega Funds was established in 2004, and today manages 6 funds with investments across Europe, North America and the Far East.

We started our firm by specializing in direct secondary transactions. Today we invest in early- and late-stage, public and private companies on both sides of the Atlantic. In addition, we continue to provide partial or complete liquidity or follow-on capital solutions for different investors in the broad life sciences space: venture and growth equity forms, corporations and other institutions.

As part of our business, we also provide follow-on capital to companies, founders and investment firms for follow-on financings, as well as collaborate with universities to invest in their leading start-ups and spin-off opportunities.